Clinical Pharmacology and Therapeutics - Table of Contents alert Volume 93 Issue 5

Advertisement Click here to download Myriad RBM’s Neuroscience Application Notes. Learn how the continued identification and characterization of novel biomarker candidates for neurodegenerative, neuropsychiatric, and neuromuscular diseases promises to make significant contributions towards early detection and the development of therapeutic intervention. TABLE OF CONTENTS Volume 93, Issue 5 (May 2013) In this issue In This Issue Editorial News & Views Perspectives Translation Discovery Development CPIC Guidelines Regulation & Use State of the Art Research Corrigendum Also new AOP Sign up for CPT: Pharmacometrics & Systems Pharmacology e-alerts Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Clinical Pharmacology & Therapeutics Accepting: - Clinical trials - Original research articles - Letters to the Editor - Reviews   In This Issue Top In This Issue Clin Pharmacol Ther 2013 93: 367; 10.1038/clpt.2013.50 Full Text Editorial Top System, Crowd, and Communal Innovation: Can the Monks Solve the Elephant? S Ito Clin Pharmacol Ther 2013 93: 369-371; 10.1038/clpt.2013.42 Abstract | Full Text News & Views Top Highlights Clin Pharmacol Ther 2013 93: 372-373; 10.1038/clpt.2013.49 Full Text ASCPT News Clin Pharmacol Ther 2013 93: 374-378; 10.1038/clpt.2013.43 Full Text Perspectives Top COMMENTARIES Systems Pharmacology for Drug Discovery and Development: Paradigm Shift or Flash in the Pan? P Vicini and P H van der Graaf Clin Pharmacol Ther 2013 93: 379-381; 10.1038/clpt.2013.40 Abstract | Full Text HIV Cure: Knocking on the Door C M Durand and C Flexner Clin Pharmacol Ther 2013 93: 382-384; 10.1038/clpt.2013.22 Abstract | Full Text Clinical Implementation of Pharmacogenetics: More than One Gene at a Time J A Johnson, T E Klein and M V Relling Clin Pharmacol Ther 2013 93: 384-385; 10.1038/clpt.2013.7 Abstract | Full Text LETTERS TO THE EDITOR HLA Allelic Variants and Carbamazepine-Induced Hypersensitivity S Grover and R Kukreti Clin Pharmacol Ther 2013 93: 386-387; advance online publication, December 27, 2012; 10.1038/clpt.2012.264 Full Text Response to “HLA Allelic Variants and Carbamazepine-Induced Hypersensitivity” V L M Yip, M Pirmohamed and A Alfirevic Clin Pharmacol Ther 2013 93: 387; advance online publication, January 17, 2013; 10.1038/clpt.2013.5 Full Text Cytochrome P450-3A Phenotyping Using Midazolam Is Not Altered by OATP1B1 Polymorphisms V C Ziesenitz, J Weiss, W E Haefeli and G Mikus Clin Pharmacol Ther 2013 93: 388; advance online publication, February 28, 2013; 10.1038/clpt.2013.46 Full Text Translation Top Interpreting Networks in Systems Biology D K Arrell and A Terzic Clin Pharmacol Ther 2013 93: 389-392; advance online publication, February 11, 2013; 10.1038/clpt.2013.28 Full Text Discovery Top A Cell Simulator Platform: The Cell Collective T Helikar, B Kowal and J A Rogers Clin Pharmacol Ther 2013 93: 393-395; advance online publication, February 20, 2013; 10.1038/clpt.2013.41 Full Text Development Top Seeking the Wisdom of Crowds Through Challenge-Based Competitions in Biomedical Research J C Costello and G Stolovitzky Clin Pharmacol Ther 2013 93: 396-398; advance online publication, February 20, 2013; 10.1038/clpt.2013.36 Full Text A Map of Alzheimer’s Disease–Signaling Pathways: A Hope for Drug Target Discovery S Ogishima, S Mizuno, M Kikuchi, A Miyashita, R Kuwano, H Tanaka and J Nakaya Clin Pharmacol Ther 2013 93: 399-401; advance online publication, February 20, 2013; 10.1038/clpt.2013.37 Full Text CPIC Guidelines Top Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants J K Hicks, J J Swen, C F Thorn, K Sangkuhl, E D Kharasch, V L Ellingrod, T C Skaar, D J Müller, A Gaedigk and J C Stingl Clin Pharmacol Ther 2013 93: 402-408; advance online publication, January 16, 2013; 10.1038/clpt.2013.2 Abstract | Full Text Regulation & Use Top PRACTICE The Liver Toxicity Knowledge Base: A Systems Approach to a Complex End Point M Chen, J Zhang, Y Wang, Z Liu, R Kelly, G Zhou, H Fang, J Borlak and W Tong Clin Pharmacol Ther 2013 93: 409-412; advance online publication, January 25, 2013; 10.1038/clpt.2013.16 Full Text State of the Art Top Systems Approaches in Risk Assessment L J Lesko, S Zheng and S Schmidt Clin Pharmacol Ther 2013 93: 413-424; advance online publication, February 11, 2013; 10.1038/clpt.2013.29 Abstract | Full Text Gatekeepers and Enablers: How Drug Regulators Respond to a Challenging and Changing Environment by Moving Toward a Proactive Attitude F Ehmann, M Papaluca Amati, T Salmonson, M Posch, S Vamvakas, R Hemmings, H G Eichler and C K Schneider Clin Pharmacol Ther 2013 93: 425-432; advance online publication, January 24, 2013; 10.1038/clpt.2013.14 Abstract | Full Text Research Top ARTICLES The Cost-Effectiveness of Periodic Safety Update Reports for Biologicals in Europe J C Bouvy, H C Ebbers, H Schellekens and M A Koopmanschap Clin Pharmacol Ther 2013 93: 433-442; advance online publication, January 24, 2013; 10.1038/clpt.2013.13 Abstract | Full Text Population Pharmacokinetics of Intramuscular Artesunate in African Children With Severe Malaria: Implications for a Practical Dosing Regimen Open ICE Hendriksen, G Mtove, A Kent, S Gesase, H Reyburn, M M Lemnge, N Lindegardh, N P J Day, L von Seidlein, N J White, A M Dondorp and J Tarning Clin Pharmacol Ther 2013 93: 443-450; advance online publication, February 8, 2013; 10.1038/clpt.2013.26 Abstract | Full Text Corrigendum Top Corrigendum: Economic and Technological Drivers of Generic Sterile Injectable Drug Shortages Clin Pharmacol Ther 2013 93: 451; advance online publication, March 20, 2013; 10.1038/clpt.2013.51 Full Text Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Clinical Pharmacology & Therapeutics. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.